Position in OGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$155,533
-$101,983 QoQ
Shares Held
11,487
-73.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#255
of 626 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 47%
Shared 0%
None 53%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Focus Partners Wealth holds $1,442,065,327 across 15 Drug Manufacturers - General names. OGN ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,488,289 | $377,980,757 | |
| 2 | LLY |
ELI LILLY & Co
|
260,045 | $311,905,800 | |
| 3 | ABBV |
AbbVie Inc.
|
929,566 | $233,915,988 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,375,512 | $176,753,292 | |
| 5 | AMGN |
Amgen Inc
|
315,585 | $114,279,640 | |
| 6 | PFE |
Pfizer Inc
|
2,693,994 | $64,871,375 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
475,579 | $60,084,650 | |
| 8 | NVS |
Novartis AG
|
235,657 | $36,932,165 |
All Filings in OGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $155,533 | 11,487 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $257,516 | 42,991 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $390,198 | 54,421 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $502,152 | 47,018 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $550,220 | 56,841 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $831,978 | 55,875 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $625,894 | 41,950 | Shares | Sole | 2025-05-20 | |
| No filing history on record for this holder in this stock. | ||||||